FDA adds boxed warning to multiple sclerosis drugs
FDA issues warning on anaphylaxis risk with MS drugs
The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any time during treatment, including months or years after starting the drug, according to a Jan. 22 news release from the agency.
Mississippi has confirmed H5N1 in a poultry flock. The birds are not part of food supply chain. What you need to know about bird flu symptoms, risk.
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
There’s more near-term competition looming however, with Biogen and Alkermes’ follow-up to Tecfidera – BIIB098 (diroximel fumarate) – due for an FDA verdict by the end of the year.
It's not illegal to drink, but selling raw cow milk is not legal in Mississippi, other than herdshare agreements. Herdshares are a contract for products like milk or meat between a farmer and ...
NFL Draft is still more than three months away, but the current owner of the No. 1 overall pick has already stirred the drama ...
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...
Low-income women in Mississippi would be able to access free prenatal care faster under a bill that has passed the House Medicaid committee.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback